Poxvirus immune modulators: Functional insights from animal models

Virus Research

Volumn 88, Issue 1-2, 2002, Pages 35-53

  Turner, Peter C ^a   Moyer, Richard W ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Chemokine; Cytokine; Immune modulator; Poxvirus; Serpin

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON RECEPTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 1BETA; SEMAPHORIN; SERINE PROTEINASE INHIBITOR; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; BIOCHEMISTRY; CELL SURFACE; GENE; HOST; IMMUNE RESPONSE; IMMUNITY; IMMUNOMODULATION; IN VITRO STUDY; INOCULATION; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; SP 1 GENE; SPI 3 GENE;

ANIMALIA; POXVIRIDAE;

EID: 0036710062     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(02)00119-3     Document Type: Review

References (130)

1. Afonso C.L., Tulman E.R., Lu Z., Oma E., Kutish G.F., Rock D.L. The genome of Melanoplus sanguinipes entomopoxvirus. J. Virol. 73:1999;533-552.
2. Afonso C.L., Tulman E.R., Lu Z., Zsak L., Kutish G.F., Rock D.L. The genome of fowlpox virus. J. Virol. 74:2000;3815-3831.
3. Afonso C.L., Tulman E.R., Lu Z., Zsak L., Osorio F.A., Balinsky C., Kutish G.F., Rock D.L. The genome of swinepox virus. J. Virol. 76:2002;783-790.
4. Alcami A., Koszinowski U.H. Viral mechanisms of immune evasion. Mol. Med. Today. 6:2000b;365-372.
5. Alcami A., Koszinowski U.H. Viral mechanisms of immune evasion. Immunol. Today. 21:2000a;447-455.
6. Alcami A., Smith G.L. A soluble receptor for interleukin-1β encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell. 71:1992;153-167.
7. Alcami A., Smith G.L. Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J. Virol. 69:1995;4633-4639.
8. Alcami A., Smith G.L. A mechanism for the inhibition of fever by a virus. Proc. Natl. Acad. Sci. USA. 93:1996;11029-11034.
9. Alcami A., Symons J.A., Collins P.D., Williams T.J., Smith G.L. Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J. Immunol. 160:1998;624-633.
10. Alcami A., Symons J.A., Smith G.L. The vaccinia virus soluble Alpha/Beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J. Virol. 74:2000;11230-11239.
11. Antoine G., Scheiflinger F., Dorner F., Falkner F.G. The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology. 244:1998;365-396.
12. Baggiolini M. Chemokines and leukocyte traffic. Nature. 392:1998;565-568.
13. Barrett J.W., Cao J.X., Hota-Mitchell S., McFadden G. Immunomodulatory proteins of myxoma virus. Semin. Immunol. 13:2001;73-84.
14. Bawden A.L., Glassberg K.J., Diggans J., Shaw R., Farmerie W., Moyer R.W. complete genomic sequence of the Amsacta moorei entomopoxvirus: analysis and comparison with other poxviruses. Virology. 274:2000;120-139.
15. Bennett M., Crouch A.J., Begon M., Duffy B., Feore S., Gaskell R.M., Kelly D.F., McCracken C.M., Vicary L., Baxby D. Cowpox in British voles and mice. J. Comp. Pathol. 116:1997;35-44.
16. Bird P.I. Serpins and regulation of cell death. Kumar S., Apoptosis: Mechanisms and Role in Disease. 1998;63-89 Springer, New York.
17. Born T.L., Morrison L.A., Esteban D.J., VandenBos T., Thebeau L.G., Chen N.H., Spriggs M.K., Sims J.E., Buller R.M.L. A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response. J. Immunol. 164:2000;3246-3254.
18. Bowie A., Kiss-Toth E., Symons J.A., Smith G.L., Dower S.K., O'Neill L.A. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc. Natl. Acad. Sci. USA. 97:2000;10162-10167.
19. Calderara S., Xiang Y., Moss B. Orthopoxvirus IL-18 binding proteins: affinities and antagonist activities. Virology. 279:2001;22-26.
20. Cameron C., Hota-Mitchell S., Chen L., Barrett J., Cao J.X., Macaulay C., Willer D., Evans D., McFadden G. The complete DNA sequence of myxoma virus. Virology. 264:1999;298-318.
21. Cao J.X., Gershon P.D., Black D.N. Sequence analysis of HindIII Q2 fragment of capripoxvirus reveals a putative gene encoding a G-protein-coupled chemokine receptor homologue. Virology. 209:1995;207-212.
22. Carfi A., Smith C.A., Smolak P.J., McGrew J., Wiley D.C. Structure of a soluble secreted chemokine inhibitor vCCI (p35) from cowpox virus. Proc. Natl. Acad. Sci. USA. 96:1999;12379-12383.
23. Colamonici O.R., Domanski P., Sweitzer S.M., Larner A., Buller R.M. Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling. J. Biol. Chem. 270:1995;15974-15978.
24. Collins P.D., Marleau S., Griffiths-Johnson D.A., Jose P.J., Williams T.J. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 182:1995;1169-1174.
25. Comeau M.R., Johnson R., DuBose R.F., Petersen M., Gearing P., VandenBos T., Park L., Farrah T., Buller R.M., Cohen J.I., Strockbine L.D., Rauch C., Spriggs M.K. A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor, VESPR. Immunity. 8:1998;473-482.
26. Damon I., Murphy P.M., Moss B. Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog. Proc. Natl. Acad. Sci. USA. 95:1998;6403-6407.
27. Dinarello C.A. IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J. Allergy Clin. Immunol. 103:1999;11-24.
28. Farber J.M. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukoc. Biol. 61:1997;246-257.
29. Fenner F. Poxviruses. Fields B.N., Knipe D.M., Howley P.M., Fields Virology. 1996;2673-2702 Lippincott-Raven, Philadelphia.
30. Fredrickson T.N., Sechler J.M., Palumbo G.J., Albert J., Khairallah L.H., Buller R.M. Acute inflammatory response to cowpox virus infection of the chorioallantoic membrane of the chick embryo. Virology. 187:1992;693-704.
31. Gardner J.D., Tscharke D.C., Reading P.C., Smith G.L. Vaccinia virus semaphorin A39R is a 50-55 kDa secreted glycoprotein that affects the outcome of infection in a murine intradermal model. J. Gen. Virol. 82:2001;2083-2093.
32. Ghayur T., Banerjee S., Hugunin M., Butler D., Herzog L., Carter A., Quintal L., Sekut L., Talanian R., Paskind M., Wong W., Kamen R., Tracey D., Allen H. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature. 386:1997;619-623.
33. Goebel S.J., Johnson G.P., Perkus M.E., Davis S.W., Winslow J.P., Paoletti E. The complete DNA sequence of vaccinia virus. Virology. 179:1990;247-266, 517-563.
34. Graham K.A., Lalani A.S., Macen J.L., Ness T.L., Barry M., Liu L.Y., Lucas A., Clark-Lewis I., Moyer R.W., McFadden G. The T1/35kDa family of poxvirus secreted proteins bind chemokines and modulate leukocyte influx into virus infected tissues. Virology. 229:1997;12-24.
35. Gu Y., Kuida K., Tsutsui H., Ku G., Hsiao K., Fleming M.A., Hayashi N., Higashino K., Okamura H., Nakanishi K., Kurimoto M., Tanimoto T., Flavell R.A., Sato V., Harding M.W., Livingston D.J., Su M.S. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science. 275:1997;206-209.
36. Howard S.T., Chan Y.S., Smith G.L. Vaccinia virus homologues of the Shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumor necrosis factor receptor family. Virology. 180:1991;633-647.
37. Hu F.Q., Smith C.A., Pickup D.J. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virology. 204:1994;343-356.
38. Isaacs S.N., Kotwal G.J., Moss B. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc. Natl. Acad. Sci. USA. 89:1992;628-632.
39. Johnson A.A., Rosengard A.M., Skjodt K., Ahearn J.M., Leslie R.G.Q. The structural basis for complement receptor type 2 (CR2, CD21)-mediated alternative pathway activation of complement: studies with CR2 deletion mutants and vaccinia virus complement-control protein-CR2 chimeras. Eur. J. Immunol. 29:1999;3837-3844.
40. Kettle S., Alcami A., Khanna A., Ehret R., Jassoy C., Smith G.L. Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1 beta-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1 beta-induced fever. J. Gen. Virol. 78:1997;677-685.
41. Kettle S., Blake N.W., Law K.M., Smith G.L. Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-1) encode M(r) 38.5 and 40K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model. Virology. 206:1995;136-147.
42. Kotwal G.J., Hugin A.W., Moss B. Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13,800-Da secreted protein. Virology. 171:1989;579-587.
43. Kotwal G.J., Isaacs S.N., McKenzie R., Frank M.M., Moss B. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science. 250:1990;827-830.
44. Kotwal G.J., Miller C.G., Justus D.E. The inflammation modulatory protein (IMP) of cowpox virus drastically diminishes the tissue damage by down-regulating cellular infiltration resulting from complement activation. Mol. Cell. Biochem. 185:1998;39-46.
45. Kotwal G.J., Moss B. Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature. 335:1988;176-178.
46. Krathwohl M.D., Hromas R., Brown D.R., Broxmeyer H.E., Fife K.H. Functional characterization of the C - C chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2. Proc. Natl. Acad. Sci. USA. 94:1997;9875-9880.
47. Lalani A.S., Graham K., Mossman K., Rajarathnam K., Clark-Lewis I., Kelvin D., McFadden G. The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines. J. Virol. 71:1997;4356-4363.
48. Lalani A.S., Masters J., Graham K., Liu L., Lucas A., McFadden G. Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M-T1, during myxoma virus pathogenesis. Virology. 256:1999;233-245.
49. Lalani A.S., McFadden G. Secreted poxvirus chemokine binding proteins. J. Leukocyte Biol. 62:1997;570-576.
50. Lalani A.S., McFadden G. Evasion and exploitation of chemokines by viruses. Cytokine Growth Factor Rev. 10:1999;219-233.
51. Lalani A.S., Ness T.L., Singh R., Harrison J.K., Seet B.T., Kelvin D.J., McFadden G., Moyer R.W. Functional comparisons among members of the poxvirus T1/35kDa family of soluble CC-chemokine inhibitor glycoproteins. Virology. 250:1998;173-184.
52. Law K.M., Smith G.L. A vaccinia serine protease inhibitor which prevents virus-induced cell fusion. J. Gen. Virol. 73:1992;549-557.
53. Lee H.J., Essani K., Smith G.L. The genome sequence of yaba-like disease virus, a yatapoxvirus. Virology. 281:2001;170-192.
54. Liu L.Y., Lalani A., Dai E.B., Seet B., Macauley C., Singh R., Fan L., McFadden G., Lucas A. The viral anti-inflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injury. J. Clin. Invest. 105:2000;1613-1621.
55. Lomas D.A., Evans D.L., Upton C., McFadden G., Carrell R.W. Inhibition of plasmin, urokinase, tissue plasminogen activator, and C1S by a myxoma virus serine proteinase inhibitor. J. Biol. Chem. 268:1993;516-521.
56. Loparev V.N., Parsons J.M., Knight J.C., Panus J.F., Ray C.A., Buller R.L., Pickup D.J., Esposito J.J. A third distinct tumor necrosis factor receptor of orthopoxviruses. Proc. Natl. Acad. Sci. USA. 95:1998;3786-3791.
57. Lucas A., Liu L.Y., Macen J., Nash P., Dai E., Stewart M., Graham K., Etches W., Boshkov L., Nation P.N., Humen D., Hobman M.L., McFadden G. Virus-encoded serine proteinase inhibitor SERP-1 inhibits atherosclerotic plaque development after balloon angioplasty. Circulation. 94:1996;2890-2900.
58. Luttichau H.R., Stine J., Boesen T.P., Johnsen A.H., Chantry D., Gerstoft J., Schwartz T.W. A highly selective CC chemokine receptor (CCR) 8 antagonist encoded by the poxvirus molluscum contagiosum. J. Exp. Med. 191:2000;171-179.
59. Macen J.L., Upton C., Nation N., McFadden G. SERP1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation. Virology. 195:1993;348-363.
60. Mahalingam S., Farber J.M., Karupiah G. The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity in vivo. J. Virol. 73:1999;1479-1491.
61. Marennikova S.S., Shelukhina E.M., Efremova E.V. New outlook on the biology of cowpox virus. Acta Virol. (Praha.). 28:1984;437-444.
62. Martinez M.J., Bray M.P., Huggins J.W. A mouse model of aerosol-transmitted orthopoxviral disease - morphology of experimental aerosol-transmitted orthopoxviral disease in a cowpox virus - BALB/c mouse system. Arch. Pathol. Lab. Med. 124:2000;362-377.
63. Martinez-Pomares L., Thompson J.P., Moyer R.W. Mapping and investigation of the role in pathogenesis of the major unique secreted 35-kDa protein of rabbitpox virus. Virology. 206:1995;591-600.
64. Massung R.F., Esposito J.J., Liu L.I., Qi J., Utterback T.R., Knight J.C., Aubin L., Yuran T.E., Parsons J.M., Loparev V.N., Selivanov N.A., Cavallaro K.F., Kerlavage A.R., Mahy B.W.J., Venter J.C. Potential virulence determinants in terminal regions of variola smallpox virus genome. Nature. 366:1993a;748-751.
65. Massung R.F., Jayarama V., Moyer R.W. DNA sequence analysis of conserved and unique regions of swinepox virus: identification of genetic elements supporting phenotypic observations including a novel G protein-coupled receptor homologue. Virology. 197:1993b;511-528.
66. Massung R.F., Liu L.I., Qi J., Knight J.C., Yuran T.E., Kerlavage A.R., Parsons J.M., Venter J.C., Esposito J.J. Analysis of the complete genome of smallpox variola major virus strain Bangladesh-1975. Virology. 201:1994;215-240.
67. McFadden G., Murphy P.M. Host-related immunomodulators encoded by poxviruses and herpesviruses. Curr. Opin. Microbiol. 3:2000;371-378.
68. McKenzie R., Kotwal G.J., Moss B., Hammer C.H., Frank M.M. Regulation of complement activity by vaccinia virus complement-control protein. J. Infect. Dis. 166:1992;1245-1250.
69. Messud-Petit F., Gelfi J., Delverdier M., Amardeilh M.F., Py R., Sutter G., Bertagnoli S. Serp2, an inhibitor of the interleukin-1β-converting enzyme, is critical in the pathobiology of myxoma virus. J. Virol. 72:1998;7830-7839.
70. Miller C.G., Justus D.E., Jayaraman S., Kotwal G.J. Severe and prolonged inflammatory response to localized cowpox virus infection in footpads of C5-deficient mice: investigation of the role of host complement in poxvirus pathogenesis. Cell Immunol. 162:1995;326-332.
71. Miller C.G., Shchelkunov S.N., Kotwal G.J. The cowpox virus-encoded homolog of the vaccinia virus complement control protein is an inflammation modulatory protein. Virology. 229:1997;126-133.
72. Moon K.B., Turner P.C., Moyer R.W. SPI-1-dependent host range of rabbitpox virus and complex formation with cathepsin G is associated with serpin motifs. J. Virol. 73:1999;8999-9010.
73. Moss B. Poxviridae: the viruses and their replication. Fields B.N., Knipe D.M., Howley P.M., Fields Virology. 1996;2637-2672 Lippincott-Raven, Philadelphia.
74. Moss B., Shisler J.L. Immunology 101 at poxvirus U: immune evasion genes. Semin. Immunol. 13:2001;59-66.
75. Moss B., Shisler J.L., Xiang Y., Senkevich T.G. Immune-defense molecules of molluscum contagiosum virus, a human poxvirus. Trends Microbiol. 8:2000;473-477.
76. Mossman K., Nation P., Macen J., Garbutt M., Lucas A., McFadden G. Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology. 215:1996;17-30.
77. Mossman K., Upton C., Buller R.M., McFadden G. Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins. Virology. 208:1995a;762-769.
78. Mossman K., Upton C., McFadden G. The myxoma virus-soluble interferon-gamma receptor homolog, M-T7, inhibits interferon-gamma in a species-specific manner. J. Biol. Chem. 270:1995b;3031-3038.
79. Murthy K.H.M., Smith S.A., Ganesh V.K., Judge K.W., Mullin N., Barlow P.N., Ogata C.M., Kotwal G.J. Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans. Cell. 104:2001;301-311.
80. Nash P., Barrett J., Cao J.X., Hota-Mitchell S., Lalani A.S., Everett H., Xu X.M., Robichaud J., Hnatiuk S., Ainslie C., Seet B.T., McFadden G. Immunomodulation by viruses: the myxoma virus story. Immunol. Rev. 168:1999;103-120.
81. Nash P., Whitty A., Handwerker J., Macen J., McFadden G. Inhibitory specificity of the anti-inflammatory myxoma virus serpin, SERP-1. J. Biol. Chem. 273:1998;20982-20991.
82. Novick D., Kim S.H., Fantuzzi G., Reznikov L.L., Dinarello C.A., Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity. 10:1999;127-136.
83. O'Neill L. The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence. Biochem. Soc. Trans. 28:2000;557-563.
84. Palumbo G.J., Pickup D.J., Fredrickson T.N., McIntyre L.J., Buller R.M. Inhibition of an inflammatory response is mediated by a 38-kDa protein of cowpox virus. Virology. 172:1989;262-273.
85. Petit F., Bertagnoli S., Gelfi J., Fassy F., Boucraut-Baralon C., Milon A. Characterization of a myxoma virus-encoded serpin-like protein with activity against interleukin-1β converting enzyme. J. Virol. 70:1996;5860-5866.
86. Pickup D.J., Ink B.S., Hu W., Ray C.A., Joklik W.K. Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases. Proc. Natl. Acad. Sci. USA. 83:1986;7698-7702.
87. Potempa J., Korzus E., Travis J. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J. Biol. Chem. 269:1994;15957-15960.
88. Quan L.T., Caputo A., Bleackley R.C., Pickup D.J., Salvesen G.S. Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A. J. Biol. Chem. 270:1995;10377-10379.
89. Ray C.A., Black R.A., Kronheim S.R., Greenstreet T.A., Sleath P.R., Salvesen G.S., Pickup D.J. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell. 69:1992;597-604.
90. Rosengard A.M., Alonso L.C., Korb L.C., Baldwin W.M., Sanfilippo F., Turka L.A., Ahearn J.M. Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP). Mol. Immunol. 36:1999;685-697.
91. Sahu A., Isaacs S.N., Soulika A.M., Lambris J.D. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b(1) inactivates the alternative complement pathway. J. Immunol. 160:1998;5596-5604.
92. Saraiva M., Alcami A. CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses. J. Virol. 75:2001;226-233.
93. Schreiber M., Rajarathnam K., McFadden G. Myxoma virus T2 protein, a tumor necrosis factor (TNF) receptor homolog, is secreted as a monomer and dimer that each bind rabbit TNFalpha, but the dimer is a more potent TNF inhibitor. J. Biol. Chem. 271:1996;13333-13341.
94. Seet B.T., Singh R., Paavola C., Lau E.K., Handel T.M., McFadden G. Molecular determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitor. Proc. Natl. Acad. Sci. USA. 98:2001;9008-9013.
95. Senkevich T.G., Bugert J.J., Sisler J.R., Koonin E.V., Darai G., Moss B. Genome sequence of a human tumorigenic poxvirus: prediction of specific host response-evasion genes. Science. 273:1996;813-816.
96. Senkevich T.G., Koonin E.V., Bugert J.J., Darai G., Moss B. The genome of molluscum contagiosum virus: analysis and comparison with other poxviruses. Virology. 233:1997;19-42.
97. Shchelkunov S.N., Blinov V.M., Sandakhchiev L.S. Genes of variola and vaccinia viruses necessary to overcome the host protective mechanisms. FEBS Lett. 319:1993;80-83.
98. Shchelkunov S.N., Totmenin A.V., Babkin I.V., Safronov P.F., Ryazankina O.I., Petrov N.A., Gutorov V.V., Uvarova E.A., Mikheev M.V., Sisler J.R., Esposito J.J., Jahrling P.B., Moss B., Sandakhchiev L.S. Human monkeypox and smallpox viruses: genomic comparison. FEBS Lett. 509:2001;66-70.
99. Shi W., Kumanogoh A., Watanabe C., Uchida J., Wang X.S., Yasui T., Yukawa K., Ikawa M., Okabe M., Parnes J.R., Yoshida K., Kikutani H. The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice. Immunity. 13:2000;633-642.
100. Silverman G.A., Bird P.I., Carrell R.W., Church F.C., Coughlin P.B., Gettins P.G., Irving J.A., Lomas D.A., Luke C.J., Moyer R.W., Pemberton P.A., Remold-O'Donnell E., Salvesen G.S., Travis J., Whisstock J.C. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem. 276:2001;33293-33296.
101. Smith C.A., Davis T., Wignall J.M., Din W.S., Farrah T., Upton C., McFadden G., Goodwin R.G. T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor. Biochem. Biophys. Res. Commun. 176:1991a;335-342.
102. Smith C.A., Hu F.Q., Smith T.D., Richards C.L., Smolak P., Goodwin R.G., Pickup D.J. Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha. Virology. 223:1996;132-147.
103. Smith C.A., Smith T.D., Smolak P.J., Friend D., Hagen H., Gerhart M., Park L., Pickup D.J., Torrance D., Mohler K., Schooley K., Goodwin R.G. Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors. Virology. 236:1997;316-327.
104. Smith G.L. Vaccinia virus immune evasion. Immunol. Lett. 65:1999;55-62.
105. Smith G.L., Chan Y.S. Two vaccinia virus proteins structurally related to the interleukin-1 receptor and the immunoglobulin superfamily. J. Gen. Virol. 72:1991;511-518.
106. Smith G.L., Chan Y.S., Howard S.T. Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat. J. Gen. Virol. 72:1991b;1349-1376.
107. Smith V.P., Alcami A. Expression of secreted cytokine and chemokine inhibitors by ectromelia virus. J. Virol. 74:2000;8460-8471.
108. Smith V.P., Alcami A. Inhibition of interferons by ectromelia virus. J. Virol. 76:2002;1124-1134.
109. Smith V.P., Bryant N.A., Alcami A. Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins. J. Gen. Virol. 81:(Part 5):2000;1223-1230.
110. Spriggs M.K., Hruby D.E., Maliszeswki C.R., Pickup D.J., Sims J.E., Buller R.M.L., VanSlyke J. Vaccinia and cowpox viruses encode a novel secreted interleukin-1 binding protein. Cell. 71:1992;145-152.
111. Symons J.A., Alcami A., Smith G.L. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell. 81:1995;551-560.
112. Tanaka-Kataoka M., Kunikata T., Takayama S., Iwaki K., Ohashi K., Ikeda M., Kurimoto M. In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection. Cytokine. 11:1999;593-599.
113. Thompson J.P., Turner P.C., Ali A.N., Crenshaw B.C., Moyer R.W. The effects of serpin gene mutations on the distinctive pathobiology of cowpox and rabbitpox virus following intranasal inoculation of Balb/c mice. Virology. 197:1993;328-338.
114. Tscharke D.C., Smith G.L. A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae. J. Gen. Virol. 80:1999;2751-2755.
115. Tulman E.R., Afonso C.L., Lu Z., Zsak L., Kutish G.F., Rock D.L. Genome of lumpy skin disease virus. J. Virol. 75:2001;7122-7130.
116. Turner P.C., Baquero M.T., Yuan S., Thoennes S.R., Moyer R.W. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase - type and tissue - type plasminogen activators and plasmin. Virology. 272:2000a;267-280.
117. Turner P.C., Moyer R.W. Orthopoxvirus fusion inhibitor glycoprotein SPI-3 (open reading frame K2L) contains motifs characteristic of serine proteinase inhibitors that are not required for control of cell fusion. J. Virol. 69:1995;5978-5987.
118. Turner P.C., Sancho M.C., Thoennes S.R., Caputo A., Bleackley R.C., Moyer R.W. Myxoma virus Serp2 is a weak inhibitor of granzyme B and interleukin-1 beta-converting enzyme in vitro and unlike CrmA cannot block apoptosis in cowpox virus-infected cells. J. Virol. 73:1999a;6394-6404.
119. Turner S., Kenshole B., Ruby J. Viral modulation of the host response via crmA/SPI-2 expression. Immunol. Cell. Biol. 77:1999b;236-241.
120. Turner S.J., Silke J., Kenshole B., Ruby J. Characterization of the ectromelia virus serpin, SPI-2. J. Gen. Virol. 81:2000b;2425-2430.
121. Upton C., Delange A.M., McFadden G. Tumorigenic poxviruses: genomic organization and DNA sequence of the telomeric region of the Shope fibroma virus genome. Virology. 160:1987;20-30.
122. Upton C., Macen J.L., Schreiber M., McFadden G. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology. 184:1991;370-382.
123. Upton C., Macen J.L., Wishart D.S., McFadden G. Myxoma virus and malignant rabbit fibroma virus encode a serpin-like protein important for virus virulence. Virology. 179:1990;618-631.
124. Upton C., Mossman K., McFadden G. Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science. 258:1992;1369-1372.
125. Verardi P.H., Jones L.A., Aziz F.H., Ahmad S., Yilma T.D. Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated in vivo without a concomitant reduction in immunogenicity. J. Virol. 75:2001;11-18.
126. Willer D.O., McFadden G., Evans D.H. The complete genome sequence of shope (Rabbit) fibroma virus. Virology. 264:1999;319-343.
127. Xiang Y., Moss B. Identification of human and mouse homologs of the MC51L-53L-54L family of secreted glycoproteins encoded by the Molluscum contagiosum poxvirus. Virology. 257:1999a;297-302.
128. Xiang Y., Moss B. IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins. Proc. Natl. Acad. Sci. USA. 96:1999b;11537-11542.
129. Xiang Y., Moss B. Correspondence of the functional epitopes of poxvirus and human interleukin-18-binding proteins. J. Virol. 75:2001a;9947-9954.
130. Xiang Y., Moss B. Determination of the functional epitopes of human interleukin-18-binding protein by site-directed mutagenesis. J. Biol. Chem. 276:2001b;17380-17386.